clinicalomicsprowebdirectory
News
Topics
Informatics
Molecular Dx
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Multimedia
eBooks
Webinars
Virtual Events
Learning Labs
Podcasts
Inside Precision Medicine Live
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Search
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Blood Disorders
Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy
Coronavirus
Study Defines Four Distinct Phenotypes of Long COVID
Lung Cancer
Tagrisso Doubles Survival Rate in EGFR Positive Lung Cancer
News & Features
Rare Mutations Confer Risk of Common Diseases
Molecular Dx
Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial…
Topics
Informatics
Molecular Dx
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Multimedia
eBooks
Webinars
Virtual Events
Learning Labs
Podcasts
Inside Precision Medicine Live
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Home
Authors
Posts by Patricia Fitzpatrick Dimond, Ph.D.
Patricia Fitzpatrick Dimond, Ph.D.
21 POSTS
0 COMMENTS
Ph.D.
Applications
Precision Biomarkers and Medicines Go Global
November 1, 2018
Applications
Tumor Biomarkers Culled from Errant Transcripts
February 7, 2018
Infectious Diseases
Multiplexed Sequencing for Novel Viral Pathogens
June 1, 2016
Big Data
Big Data’s Big Implications for Cancer Treatments
May 2, 2016
Assay Development
Finer Cancer Screens Catch More Cancer Clues
March 31, 2016
Molecular Dx
Clinical Actionability in Cancer
February 29, 2016
Molecular Dx
Proteomics for Disease Detection and Characterization
January 29, 2016
News & Features
Precision Medicine in Oncology
January 4, 2016
Epigenetics
Identifying Susceptibility Genes and Epigenetic Mechanisms for Drugs of Abuse
November 30, 2015
Companion Diagnostics
Companion Diagnostics for Cancer: Will NGS Play a Role?
October 30, 2015
1
2
3
Page 1 of 3
Trending
Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy
June 5, 2023
Study Defines Four Distinct Phenotypes of Long COVID
June 5, 2023
Rare Mutations Confer Risk of Common Diseases
June 2, 2023
Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching
June 2, 2023
Inside Precision Medicine
![One key outcome of the use of mass spec in the NIH’s Clinical Proteomic Technologies for Cancer program has been the improvement of the proteomic biomarker development pipeline. [iStock / nan_bkk]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/487-324x160.jpeg "Proteomics for Disease Detection and Characterization")
![The White House has proposed $70 million in increased funding for the National Cancer Institute to advance the field of precision oncology. [iStock/KatarzynaBialasiewicz]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/446-324x160.jpeg "Precision Medicine in Oncology")
![Pharmaceutical manufacturers have found that using companion diagnostics during drug development improves the success rate of therapeutics being tested in clinical trials. [iStock/anna1311]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/355-324x160.jpeg "Companion Diagnostics for Cancer: Will NGS Play a Role?")
